A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

• Status: Completed
• Trial end date: 2005-07-25
• Target enrollment: 0
• Participant gender: Male

Summary

The purpose of this trial is to determine the efficacy and safety of an investigational drug in patients with benign prostatic hyperplasia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Finasteride

Criteria

Inclusion Criteria:

• Patients with benign prostatic hyperplasia

Exclusion Criteria:

• Patients who are suspected to be suffering from prostatic cancer